Evidence map›Paper›PMID 32629642›Full record

ArticleMedicine2020

Acupuncture for breathlessness in COVID-19: A protocol for systematic review and meta-analysis.

Baozhen Zhang, Kai Zhang, Qilin Tang, Kaihang Sun, Zhenzhen Han

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05890508 (Electro-acupuncture for Long Covid Neuropsychiatric Symptoms), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05890508 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms: a Prospective, Randomized Sham-controlled, Double-blinded Clinical Trial

TypeinterventionalSponsorHong Kong Baptist UniversityRan2024 to 2026Enrolled150ConditionsLong Covid19, Neuropsychiatric Symptoms, Electro-acupunctureArmsAcupuncture, Sham-acupuncture
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Acupoint stimulation for long COVID: A promising intervention:.World journal of acupuncture-moxibustion · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Baozhen ZhangDepartment of Health Management, Tianjin Rehabilitation and Convalescence Center of PLA.ORCID 0000-0001-9032-054
Kai ZhangDepartment of Acupuncture and Moxibustion, Tianjin Gong An Hospital, Tianjin.ORCID 0000-0002-7248-1451
Qilin TangSchool of Basic Medical Sciences, Hebei University of Chinese Medicine, Hebei, Shijiazhuang.
Kaihang SunDepartment of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Zhenzhen HanDepartment of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CNHebei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt present, accumulative attention has been paid to coronavirus disease 2019 (COVID-19) due to its global prevalence. Acupuncture may play a beneficial role in patients with breathlessness in COVID-19. This study is designed to determine the efficacy and safety of acupuncture for breathlessness in COVID-19.

methodsRandomized controlled trials (RCT) will be searched from 7 electronic databases, with the last search update being 30 June 2020. Studies by registers of clinical trials will be additionally searched. Two investigators will independently select studies, extract data and evaluate study quality. Finally, a meta-analysis will be used to evaluate the pooled intervention effect if possible.

resultsOur present findings will indicate the application of acupuncture as an adjunctive treatment for dyspnea in COVID-19, which will be published in a peer-reviewed journal.

conclusionOur study will provide a reference foundation for clinical optimization of treatment. PROSPERO REGISTRATION NUMBER: CRD42020182323.

Indexed as

Acupuncture TherapyBetacoronavirusCombined Modality TherapyCoronavirus InfectionsCOVID-19DyspneaHumansMeta-Analysis as TopicPandemicsPneumonia, ViralSARS-CoV-2Systematic Reviews as Topic

Identifiers

PMID32629642
PMCPMC7337514
OpenAlexW3037186681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.